137 related articles for article (PubMed ID: 19356484)
1. T2* magnetic resonance: iron and gold.
Pennell DJ
JACC Cardiovasc Imaging; 2008 Sep; 1(5):579-81. PubMed ID: 19356484
[No Abstract] [Full Text] [Related]
2. Relationship of magnetic resonance imaging estimation of myocardial iron to left ventricular systolic and diastolic function in thalassemia.
Leonardi B; Margossian R; Colan SD; Powell AJ
JACC Cardiovasc Imaging; 2008 Sep; 1(5):572-8. PubMed ID: 19356483
[TBL] [Abstract][Full Text] [Related]
3. Thalassemia: cardiac iron and chelators.
Gaur A
Indian Pediatr; 2012 Apr; 49(4):268-9. PubMed ID: 22565070
[No Abstract] [Full Text] [Related]
4. Assessment of iron overload with T2* magnetic resonance imaging.
Anderson LJ
Prog Cardiovasc Dis; 2011; 54(3):287-94. PubMed ID: 22014495
[TBL] [Abstract][Full Text] [Related]
5. Cardiopulmonary exercise testing in thalassemia.
Carpenter JP; Pennell DJ
Int J Cardiovasc Imaging; 2009 Dec; 25(8):785-8. PubMed ID: 19937125
[No Abstract] [Full Text] [Related]
6. Early detection of iron overload in the heart: a key role for MRI!
Baur LH
Int J Cardiovasc Imaging; 2009 Dec; 25(8):789-90. PubMed ID: 19937124
[No Abstract] [Full Text] [Related]
7. T2* magnetic resonance and myocardial iron in thalassemia.
Pennell DJ
Ann N Y Acad Sci; 2005; 1054():373-8. PubMed ID: 16339685
[TBL] [Abstract][Full Text] [Related]
8. Uses and limitations of serum ferritin, magnetic resonance imaging T2 and T2* in the diagnosis of iron overload and in the ferrikinetics of normalization of the iron stores in thalassemia using the International Committee on Chelation deferiprone/deferoxamine combination protocol.
Kolnagou A; Yazman D; Economides C; Eracleous E; Kontoghiorghes GJ
Hemoglobin; 2009; 33(5):312-22. PubMed ID: 19814677
[TBL] [Abstract][Full Text] [Related]
9. Cardioprotective effect of iron chelators.
Hershko C; Link G; Konijn AM
Adv Exp Med Biol; 2002; 509():77-89. PubMed ID: 12572990
[No Abstract] [Full Text] [Related]
10. Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance.
Anderson LJ; Westwood MA; Holden S; Davis B; Prescott E; Wonke B; Porter JB; Walker JM; Pennell DJ
Br J Haematol; 2004 Nov; 127(3):348-55. PubMed ID: 15491298
[TBL] [Abstract][Full Text] [Related]
11. Effect of iron overload on exercise capacity in thalassemic patients with heart failure.
Mavrogeni S; Gotsis E; Verganelakis D; Berdousis E; Dritsas A; Kolovou G; Toulas P; Ladis V
Int J Cardiovasc Imaging; 2009 Dec; 25(8):777-83. PubMed ID: 19680779
[TBL] [Abstract][Full Text] [Related]
12. Detection of the cardiovascular complications of thalassemia by echocardiography.
Walker JM; Nair S
Ann N Y Acad Sci; 2010 Aug; 1202():165-72. PubMed ID: 20712789
[TBL] [Abstract][Full Text] [Related]
13. Left ventricular diastolic function compared with T2* cardiovascular magnetic resonance for early detection of myocardial iron overload in thalassemia major.
Westwood MA; Wonke B; Maceira AM; Prescott E; Walker JM; Porter JB; Pennell DJ
J Magn Reson Imaging; 2005 Aug; 22(2):229-33. PubMed ID: 16028255
[TBL] [Abstract][Full Text] [Related]
14. Physiology and pathophysiology of iron cardiomyopathy in thalassemia.
Wood JC; Enriquez C; Ghugre N; Otto-Duessel M; Aguilar M; Nelson MD; Moats R; Coates TD
Ann N Y Acad Sci; 2005; 1054():386-95. PubMed ID: 16339687
[TBL] [Abstract][Full Text] [Related]
15. [Value of magnetic resonance imaging T2* tests in detecting heart and liver iron overload in patients with β-thalassemia major].
Wu X; Jing Y; Pei F; Chen J; Feng X; He Y; Zhang Y; Li C
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Feb; 33(2):249-52. PubMed ID: 23443782
[TBL] [Abstract][Full Text] [Related]
16. Myocyte damage and loss of myofibers is the potential mechanism of iron overload toxicity in congestive cardiac failure in thalassemia. Complete reversal of the cardiomyopathy and normalization of iron load by deferiprone.
Kolnagou A; Michaelides Y; Kontos C; Kyriacou K; Kontoghiorghes GJ
Hemoglobin; 2008; 32(1-2):17-28. PubMed ID: 18274979
[TBL] [Abstract][Full Text] [Related]
17. MRI for Iron Overload in Thalassemia.
Fernandes JL
Hematol Oncol Clin North Am; 2018 Apr; 32(2):277-295. PubMed ID: 29458732
[TBL] [Abstract][Full Text] [Related]
18. Assessment of cardiac and hepatic iron overload in thalassaemic patients by magnetic resonance: a four year observational study.
Candini G; Lappi S
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():204-7. PubMed ID: 19337179
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic iron overload by T2* MRI in a large cohort of well treated thalassemia major patients: can it tell us heart iron distribution and function?
Meloni A; Restaino G; Missere M; De Marchi D; Positano V; Valeri G; Giuseppe D'Ascola D; Peluso A; Caterina Putti M; Lendini M; Giovanna Neri M; Midiri M; Sallustio G; Pepe A
Am J Hematol; 2015 Sep; 90(9):E189-90. PubMed ID: 26044155
[No Abstract] [Full Text] [Related]
20. A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance.
Tanner MA; Galanello R; Dessi C; Smith GC; Westwood MA; Agus A; Roughton M; Assomull R; Nair SV; Walker JM; Pennell DJ
Circulation; 2007 Apr; 115(14):1876-84. PubMed ID: 17372174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
